close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar28Point48
Implied share price

Sell Overvalued by 78.2%

5% margin of safety What's this?

EV / EBITDA
Use Average
ALXN
Alexion Pharmaceuticals, Inc.
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
9.92 36.83 12.21 4.95 17.08 5.09
All amounts in millions
from last financial year
         
Implied Share Price $28.48 $141.23 $169.44 $56.52 $80.16
Market Cap 29,232 130,102 107,921 100,042 98,744
Net Debt 2,035 47 7,450 -3,369 7,330
Enterprise Value (EV) 31,268 130,149 115,371 96,673 56,725
Revenue 2,604 21,662 32,639 13,418 34,861
EBITDA 848 10,657 23,287 5,661 11,136
Percent 32.6 % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 682 8,530 22,189 5,069 7,186
Percent 26.2 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 13,097 71,449 51,716 21,787 102,321
Total Liabilities 4,839 43,366 33,182 6,116 44,272
Shareholders Equity 8,258 28,083 18,534 15,671 58,049.0

Comments

No comments yet. Login to comment.